China Active Pharmaceutical Ingredients (API) Market Report & Forecast 2021-2027

1 Introduction to Research & Analysis Reports
1.1 Active Pharmaceutical Ingredients (API) Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Active Pharmaceutical Ingredients (API) Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Active Pharmaceutical Ingredients (API) Overall Market Size
2.1 China Active Pharmaceutical Ingredients (API) Market Size: 2021 VS 2027
2.2 China Active Pharmaceutical Ingredients (API) Revenue, Prospects & Forecasts: 2016-2027
2.3 China Active Pharmaceutical Ingredients (API) Sales: 2016-2027

3 Company Landscape
3.1 Top Active Pharmaceutical Ingredients (API) Players in China Market
3.2 Top China Active Pharmaceutical Ingredients (API) Companies Ranked by Revenue
3.3 China Active Pharmaceutical Ingredients (API) Revenue by Companies
3.4 China Active Pharmaceutical Ingredients (API) Sales by Companies
3.5 China Active Pharmaceutical Ingredients (API) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Active Pharmaceutical Ingredients (API) Companies in China Market, by Revenue in 2020
3.7 Manufacturers Active Pharmaceutical Ingredients (API) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) Players in China Market
3.8.1 List of Tier 1 Active Pharmaceutical Ingredients (API) Companies in China
3.8.2 List of Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Active Pharmaceutical Ingredients (API) Market Size Markets, 2021 & 2027
4.1.2 Synthetic APIs
4.1.3 Biotech APIs
4.2 By Type - China Active Pharmaceutical Ingredients (API) Revenue & Forecasts
4.2.1 By Type - China Active Pharmaceutical Ingredients (API) Revenue, 2016-2021
4.2.2 By Type - China Active Pharmaceutical Ingredients (API) Revenue, 2022-2027
4.2.3 By Type - China Active Pharmaceutical Ingredients (API) Revenue Market Share, 2016-2027
4.3 By Type - China Active Pharmaceutical Ingredients (API) Sales & Forecasts
4.3.1 By Type - China Active Pharmaceutical Ingredients (API) Sales, 2016-2021
4.3.2 By Type - China Active Pharmaceutical Ingredients (API) Sales, 2022-2027
4.3.3 By Type - China Active Pharmaceutical Ingredients (API) Sales Market Share, 2016-2027
4.4 By Type - China Active Pharmaceutical Ingredients (API) Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Active Pharmaceutical Ingredients (API) Market Size, 2021 & 2027
5.1.2 CNS
5.1.3 Cardiovascular
5.1.4 Genitourinary/Hormonal Drugs
5.1.5 Respiratory
5.1.6 Rheumatology
5.1.7 Diabetes
5.1.8 Oncology
5.1.9 Others
5.2 By Application - China Active Pharmaceutical Ingredients (API) Revenue & Forecasts
5.2.1 By Application - China Active Pharmaceutical Ingredients (API) Revenue, 2016-2021
5.2.2 By Application - China Active Pharmaceutical Ingredients (API) Revenue, 2022-2027
5.2.3 By Application - China Active Pharmaceutical Ingredients (API) Revenue Market Share, 2016-2027
5.3 By Application - China Active Pharmaceutical Ingredients (API) Sales & Forecasts
5.3.1 By Application - China Active Pharmaceutical Ingredients (API) Sales, 2016-2021
5.3.2 By Application - China Active Pharmaceutical Ingredients (API) Sales, 2022-2027
5.3.3 By Application - China Active Pharmaceutical Ingredients (API) Sales Market Share, 2016-2027
5.4 By Application - China Active Pharmaceutical Ingredients (API) Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Overview
6.1.3 Teva Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.1.4 Teva Active Pharmaceutical Ingredients (API) Product Description
6.1.5 Teva Recent Developments
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Overview
6.2.3 Mylan Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.2.4 Mylan Active Pharmaceutical Ingredients (API) Product Description
6.2.5 Mylan Recent Developments
6.3 DSM
6.3.1 DSM Corporation Information
6.3.2 DSM Overview
6.3.3 DSM Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.3.4 DSM Active Pharmaceutical Ingredients (API) Product Description
6.3.5 DSM Recent Developments
6.4 Aurobindo Pharma
6.4.1 Aurobindo Pharma Corporation Information
6.4.2 Aurobindo Pharma Overview
6.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Description
6.4.5 Aurobindo Pharma Recent Developments
6.5 Aspen
6.5.1 Aspen Corporation Information
6.5.2 Aspen Overview
6.5.3 Aspen Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.5.4 Aspen Active Pharmaceutical Ingredients (API) Product Description
6.5.5 Aspen Recent Developments
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Overview
6.6.3 Novartis Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.6.4 Novartis Active Pharmaceutical Ingredients (API) Product Description
6.6.5 Novartis Recent Developments
6.7 BASF
6.7.1 BASF Corporation Information
6.7.2 BASF Overview
6.7.3 BASF Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.7.4 BASF Active Pharmaceutical Ingredients (API) Product Description
6.7.5 BASF Recent Developments
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Overview
6.8.3 Pfizer Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.8.4 Pfizer Active Pharmaceutical Ingredients (API) Product Description
6.8.5 Pfizer Recent Developments
6.9 Huahai Pharmaceutical
6.9.1 Huahai Pharmaceutical Corporation Information
6.9.2 Huahai Pharmaceutical Overview
6.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Description
6.9.5 Huahai Pharmaceutical Recent Developments
6.10 Hisun Pharmaceutical
6.10.1 Hisun Pharmaceutical Corporation Information
6.10.2 Hisun Pharmaceutical Overview
6.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Description
6.10.5 Hisun Pharmaceutical Recent Developments
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Corporation Information
6.11.2 Sun Pharmaceutical Industries Overview
6.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Description
6.11.5 Sun Pharmaceutical Industries Recent Developments
6.12 Zhejiang Medicine
6.12.1 Zhejiang Medicine Corporation Information
6.12.2 Zhejiang Medicine Overview
6.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Description
6.12.5 Zhejiang Medicine Recent Developments
6.13 Dr. ReddyÕs Laboratories
6.13.1 Dr. ReddyÕs Laboratories Corporation Information
6.13.2 Dr. ReddyÕs Laboratories Overview
6.13.3 Dr. ReddyÕs Laboratories Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.13.4 Dr. ReddyÕs Laboratories Active Pharmaceutical Ingredients (API) Product Description
6.13.5 Dr. ReddyÕs Laboratories Recent Developments
6.14 Zhejiang NHU
6.14.1 Zhejiang NHU Corporation Information
6.14.2 Zhejiang NHU Overview
6.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Description
6.14.5 Zhejiang NHU Recent Developments
6.15 Bayer
6.15.1 Bayer Corporation Information
6.15.2 Bayer Overview
6.15.3 Bayer Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.15.4 Bayer Active Pharmaceutical Ingredients (API) Product Description
6.15.5 Bayer Recent Developments
6.16 NCPC
6.16.1 NCPC Corporation Information
6.16.2 NCPC Overview
6.16.3 NCPC Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.16.4 NCPC Active Pharmaceutical Ingredients (API) Product Description
6.16.5 NCPC Recent Developments
6.17 AbbVie
6.17.1 AbbVie Corporation Information
6.17.2 AbbVie Overview
6.17.3 AbbVie Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.17.4 AbbVie Active Pharmaceutical Ingredients (API) Product Description
6.17.5 AbbVie Recent Developments
6.18 Shandong Xinhua Pharmaceutical
6.18.1 Shandong Xinhua Pharmaceutical Corporation Information
6.18.2 Shandong Xinhua Pharmaceutical Overview
6.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Description
6.18.5 Shandong Xinhua Pharmaceutical Recent Developments
6.19 Northeast Pharm
6.19.1 Northeast Pharm Corporation Information
6.19.2 Northeast Pharm Overview
6.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Description
6.19.5 Northeast Pharm Recent Developments
6.20 Harbin Pharmaceutical
6.20.1 Harbin Pharmaceutical Corporation Information
6.20.2 Harbin Pharmaceutical Overview
6.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Description
6.20.5 Harbin Pharmaceutical Recent Developments
6.21 LKPC
6.21.1 LKPC Corporation Information
6.21.2 LKPC Overview
6.21.3 LKPC Active Pharmaceutical Ingredients (API) Sales and Revenue in China Market (2016-2021)
6.21.4 LKPC Active Pharmaceutical Ingredients (API) Product Description
6.21.5 LKPC Recent Developments

7 China Active Pharmaceutical Ingredients (API) Production Capacity, Analysis
7.1 China Active Pharmaceutical Ingredients (API) Production Capacity, 2016-2027
7.2 Active Pharmaceutical Ingredients (API) Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Active Pharmaceutical Ingredients (API) Supply Chain Analysis
9.1 Active Pharmaceutical Ingredients (API) Industry Value Chain
9.2 Active Pharmaceutical Ingredients (API) Upstream Market
9.3 Active Pharmaceutical Ingredients (API) Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Active Pharmaceutical Ingredients (API) Distributors and Sales Agents in China Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

List of Tables
Table 1. Key Players of Active Pharmaceutical Ingredients (API) in China Market
Table 2. Top Active Pharmaceutical Ingredients (API) Players in China Market, Ranking by Revenue (2019)
Table 3. China Active Pharmaceutical Ingredients (API) Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Active Pharmaceutical Ingredients (API) Revenue Share by Companies, 2016-2021
Table 5. China Active Pharmaceutical Ingredients (API) Sales by Companies, (Tons), 2016-2021
Table 6. China Active Pharmaceutical Ingredients (API) Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Active Pharmaceutical Ingredients (API) Price (2016-2021) & (USD/Ton)
Table 8. Manufacturers Active Pharmaceutical Ingredients (API) Product Type
Table 9. List of Tier 1 Active Pharmaceutical Ingredients (API) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Active Pharmaceutical Ingredients (API) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Synthetic APIs
Table 12. Major Manufacturers of Biotech APIs
Table 13. By Type Ð China Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Active Pharmaceutical Ingredients (API) Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Active Pharmaceutical Ingredients (API) Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Active Pharmaceutical Ingredients (API) Sales (Tons), 2016-2021
Table 17. By Type - China Active Pharmaceutical Ingredients (API) Sales (Tons), 2022-2027
Table 18. By Application Ð China Active Pharmaceutical Ingredients (API) Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Active Pharmaceutical Ingredients (API) Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Active Pharmaceutical Ingredients (API) Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Active Pharmaceutical Ingredients (API) Sales (Tons), 2016-2021
Table 22. By Application - China Active Pharmaceutical Ingredients (API) Sales (Tons), 2022-2027
Table 23. Teva Corporation Information
Table 24. Teva Description and Major Businesses
Table 25. Teva Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 26. Teva Active Pharmaceutical Ingredients (API) Product
Table 27. Teva Recent Developments
Table 28. Mylan Corporation Information
Table 29. Mylan Description and Major Businesses
Table 30. Mylan Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 31. Mylan Active Pharmaceutical Ingredients (API) Product
Table 32. Mylan Recent Developments
Table 33. DSM Corporation Information
Table 34. DSM Description and Major Businesses
Table 35. DSM Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 36. DSM Active Pharmaceutical Ingredients (API) Product
Table 37. DSM Recent Developments
Table 38. Aurobindo Pharma Corporation Information
Table 39. Aurobindo Pharma Description and Major Businesses
Table 40. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 41. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product
Table 42. Aurobindo Pharma Recent Developments
Table 43. Aspen Corporation Information
Table 44. Aspen Description and Major Businesses
Table 45. Aspen Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 46. Aspen Active Pharmaceutical Ingredients (API) Product
Table 47. Aspen Recent Developments
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Major Businesses
Table 50. Novartis Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 51. Novartis Active Pharmaceutical Ingredients (API) Product
Table 52. Novartis Recent Developments
Table 53. BASF Corporation Information
Table 54. BASF Description and Major Businesses
Table 55. BASF Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 56. BASF Active Pharmaceutical Ingredients (API) Product
Table 57. BASF Recent Developments
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Major Businesses
Table 60. Pfizer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 61. Pfizer Active Pharmaceutical Ingredients (API) Product
Table 62. Pfizer Recent Developments
Table 63. Huahai Pharmaceutical Corporation Information
Table 64. Huahai Pharmaceutical Description and Major Businesses
Table 65. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 66. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 67. Huahai Pharmaceutical Recent Developments
Table 68. Hisun Pharmaceutical Corporation Information
Table 69. Hisun Pharmaceutical Description and Major Businesses
Table 70. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 71. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 72. Hisun Pharmaceutical Recent Developments
Table 73. Sun Pharmaceutical Industries Corporation Information
Table 74. Sun Pharmaceutical Industries Description and Major Businesses
Table 75. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 76. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product
Table 77. Sun Pharmaceutical Industries Recent Developments
Table 78. Zhejiang Medicine Corporation Information
Table 79. Zhejiang Medicine Description and Major Businesses
Table 80. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 81. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product
Table 82. Zhejiang Medicine Recent Developments
Table 83. Dr. ReddyÕs Laboratories Corporation Information
Table 84. Dr. ReddyÕs Laboratories Description and Major Businesses
Table 85. Dr. ReddyÕs Laboratories Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 86. Dr. ReddyÕs Laboratories Active Pharmaceutical Ingredients (API) Product
Table 87. Dr. ReddyÕs Laboratories Recent Developments
Table 88. Zhejiang NHU Corporation Information
Table 89. Zhejiang NHU Description and Major Businesses
Table 90. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 91. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product
Table 92. Zhejiang NHU Recent Developments
Table 93. Bayer Corporation Information
Table 94. Bayer Description and Major Businesses
Table 95. Bayer Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 96. Bayer Active Pharmaceutical Ingredients (API) Product
Table 97. Bayer Recent Developments
Table 98. NCPC Corporation Information
Table 99. NCPC Description and Major Businesses
Table 100. NCPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 101. NCPC Active Pharmaceutical Ingredients (API) Product
Table 102. NCPC Recent Developments
Table 103. AbbVie Corporation Information
Table 104. AbbVie Description and Major Businesses
Table 105. AbbVie Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 106. AbbVie Active Pharmaceutical Ingredients (API) Product
Table 107. AbbVie Recent Developments
Table 108. Shandong Xinhua Pharmaceutical Corporation Information
Table 109. Shandong Xinhua Pharmaceutical Description and Major Businesses
Table 110. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 111. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 112. Shandong Xinhua Pharmaceutical Recent Developments
Table 113. Northeast Pharm Corporation Information
Table 114. Northeast Pharm Description and Major Businesses
Table 115. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 116. Northeast Pharm Active Pharmaceutical Ingredients (API) Product
Table 117. Northeast Pharm Recent Developments
Table 118. Harbin Pharmaceutical Corporation Information
Table 119. Harbin Pharmaceutical Description and Major Businesses
Table 120. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 121. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product
Table 122. Harbin Pharmaceutical Recent Developments
Table 123. LKPC Corporation Information
Table 124. LKPC Description and Major Businesses
Table 125. LKPC Active Pharmaceutical Ingredients (API) Sales (Tons), Revenue (US$, Mn) and Gross Margin (USD/Ton) (2016-2021)
Table 126. LKPC Active Pharmaceutical Ingredients (API) Product
Table 127. LKPC Recent Developments
Table 128. Active Pharmaceutical Ingredients (API) Production Capacity (Tons) of Key Manufacturers in China Market, 2019-2021 (Tons)
Table 129. China Active Pharmaceutical Ingredients (API) Capacity Market Share of Key Manufacturers, 2019-2021
Table 130. Active Pharmaceutical Ingredients (API) Market Opportunities & Trends in China Market
Table 131. Active Pharmaceutical Ingredients (API) Market Drivers in China Market
Table 132. Active Pharmaceutical Ingredients (API) Market Restraints in China Market
Table 133. Active Pharmaceutical Ingredients (API) Raw Materials
Table 134. Active Pharmaceutical Ingredients (API) Raw Materials Suppliers in China Market
Table 135. Typical Active Pharmaceutical Ingredients (API) Downstream
Table 136. Active Pharmaceutical Ingredients (API) Downstream Clients in China Market
Table 137. Active Pharmaceutical Ingredients (API) Distributors and Sales Agents in China Market
List of Figures
Figure 1. Active Pharmaceutical Ingredients (API) Product Picture
Figure 2. Active Pharmaceutical Ingredients (API) Segment by Type
Figure 3. Active Pharmaceutical Ingredients (API) Segment by Application
Figure 4. China Active Pharmaceutical Ingredients (API) Market Overview: 2020
Figure 5. China Active Pharmaceutical Ingredients (API) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Active Pharmaceutical Ingredients (API) Revenue, 2016-2027 (US$, Mn)
Figure 7. Active Pharmaceutical Ingredients (API) Sales in China Market: 2016-2027 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2020
Figure 9. Synthetic APIs Product Picture
Figure 10. Biotech APIs Product Picture
Figure 11. By Type - China Active Pharmaceutical Ingredients (API) Sales Market Share, 2016-2027
Figure 12. By Type - China Active Pharmaceutical Ingredients (API) Revenue Market Share, 2016-2027
Figure 13. By Type - China Active Pharmaceutical Ingredients (API) Price (USD/Ton), 2016-2027
Figure 14. CNS
Figure 15. Cardiovascular
Figure 16. Genitourinary/Hormonal Drugs
Figure 17. Respiratory
Figure 18. Rheumatology
Figure 19. By Application - China Active Pharmaceutical Ingredients (API) Sales Market Share, 2016-2027
Figure 20. By Application - China Active Pharmaceutical Ingredients (API) Revenue Market Share, 2016-2027
Figure 21. By Application - China Active Pharmaceutical Ingredients (API) Price (USD/Ton), 2016-2027
Figure 22. Teva Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Mylan Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. DSM Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Aspen Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Novartis Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. BASF Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Pfizer Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Dr. ReddyÕs Laboratories Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Zhejiang NHU Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Bayer Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. NCPC Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AbbVie Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Northeast Pharm Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. LKPC Active Pharmaceutical Ingredients (API) Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. China Active Pharmaceutical Ingredients (API) Production Capacity (Tons), 2016-2027
Figure 44. Active Pharmaceutical Ingredients (API) Industry Value Chain
Figure 45. Marketing Channels

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.